February 26, 2021

Nano Well-being Health Recalls Super Arthgold

La Mirada, Nano Well-being Health Inc. is recalling two lots of Super Arthgold, a dietary supplement marketed for joint pain and arthritis, because it contains chlorzoxazone, diclofenac, and indomethacin, making it an unapproved new drug. The FDA states that “use of this product has a reasonable probability of resulting in fatal adverse events in consumers with underlying illnesses.” Those illnesses include allergies to the hidden ingredients, cardiac, GI, hepatic, and renal conditions, as well as anyone who has recently undergone cardiac bypass graft surgery.

Super Arthgold RecallThe product contains NSAIDs as well, which could lead to an overdose in those who are already taking that over-the-counter pain reliever. NSAID overdose can lead to heart attack, stroke, congestive heart failure, renal toxicity, ulceration, and bleeding of the stomach or intestines.

The recalled product is Super Arthgold in 500 mg capsules. The lot numbers are L1P1-6100/Expiration date June 25, 2016; and L1P2-6000/Expiration date September 16, 2016. The company is notifying distributors and customers by peter and phone call and arranging for replacement of all recalled products.

If you purchased this product, do not consume it. Return it to the place of purchase for a refund or replacement. If you have experienced health problems taking this product, see your health care provider as soon as possible. You can report adverse reactions to the FDA’s MedWatch Adverse Event Reporting program.

Report Your Food Poisoning Case
[contact-form-7 404 "Not Found"]

Home About Site Map Contact Us Sponsored by Pritzker Hageman, P.A., a Minneapolis, MN law firm that helps food poisoning victims nationally.